UFP TECHNOLOGIES INC quarterly report, Q2 FY2014

UFP Technologies, Inc. — Q2 2014 Form 10-Q

Business context and reporting period. The company designs and manufactures foam, plastics, composite, and natural-fiber products, primarily for medical, aerospace and defense, automotive, and packaging markets. This unaudited filing covers the quarter and six months ended June 30, 2014; comparisons are with the corresponding 2013 periods.

Financial performance

MetricQ2 2014Q2 2013Six months 2014Six months 2013
Net sales$34.025m$35.832m$68.634m$69.529m
Gross profit$9.476m$10.719m$18.584m$19.621m
Gross margin27.9%29.9%27.1%28.2%
Operating income$2.788m$4.633m$5.982m$7.589m
Net income$1.860m$2.982m$3.922m$5.012m
Diluted EPS$0.26$0.42$0.55$0.71
  • Operating margins were approximately 8.2% for Q2 2014 versus 12.9% a year earlier, and 8.7% for the first half versus 10.9%. Net margins were approximately 5.5% and 8.3% for Q2, and 5.7% and 7.2% for the first half, respectively.
  • For the first half, operating cash flow was $1.942m, investing cash flow was negative $7.255m, and financing cash flow was negative $0.030m. Cash declined $5.343m to $31.960m.
  • At June 30, cash was $31.960m; total assets were $108.884m and stockholders’ equity was $90.698m. Total debt was approximately $3.357m, comprising $0.985m current and $2.372m long-term.
  • The company had no borrowings on its unsecured $40m revolving credit facility and reported compliance with its covenants. The facility matures November 30, 2018. Separate term loans related to molded-fiber machines carried a fixed 1.83% rate and had an outstanding balance of approximately $3.4m.

Changes and operating drivers

  • Q2 sales fell 5.0%; first-half sales declined 1.3%. Management attributed the weakness mainly to aerospace and defense sales declines of 25.1% in Q2 and 19.2% for the first half, related to government spending cuts. Q2 automotive sales also declined 16.2%, largely due to customer plant shutdowns.
  • First-half molded-fiber packaging sales rose 9.1%, partly offsetting the aerospace and defense decline. Segment first-half sales were $47.499m for Component Products and $21.135m for Packaging, compared with $47.659m and $21.870m in 2013.
  • Lower sales against fixed overhead, higher depreciation, and increased employee health-care costs reduced gross margin. SG&A rose 6.4% in Q2 and 2.2% for the first half, reflecting such items as ERP-related depreciation, compensation, director compensation, and a large-account bad-debt write-off.
  • First-half operating cash generation was affected by a $2.381m inventory increase, a $0.991m increase in prepaid expenses, and a $1.431m decline in accrued taxes and other expenses; these were partly offset by higher accounts payable and refundable income taxes.

Outlook, plans, and risks

  • No quantified company-wide revenue or earnings guidance is provided. Management expected aerospace and defense sales to improve in the second half based on customer forecasts, while cautioning that further restructuring charges were expected.
  • The Illinois-to-Michigan plant consolidation was expected to entail approximately $1.15m of one-time expenses plus approximately $0.3m of building improvements; total cash charges were estimated at $1.45m. Expected annual savings were approximately $0.75m. The company recorded $0.324m of restructuring costs in the first half.
  • After quarter-end, the company committed to consolidate its Costa Mesa, California plant into Rancho Dominguez and other facilities. It estimated $0.535m of one-time costs and approximately $0.55m in annual savings, with completion expected by year-end 2014.
  • The company completed a roughly $3.0m purchase of an El Paso, Texas facility on July 1, 2014. It planned to relocate existing operations there and add two molded-fiber manufacturing lines expected to operate by Q1 2015.
  • Management believed existing resources, operating cash, and available financing would cover requirements, including capital expenditures, for the next 12 months, but stated that longer-term liquidity depends on operating performance. Disclosed risks include economic and customer demand conditions, customer order cancellations or delays, competition, acquisitions, new equipment implementation and utilization, and execution of plant consolidations and expected savings. No material changes to previously disclosed risk factors or market risks were reported.
  • Disclosure controls were assessed as effective; the filing reported no material change in internal control over financial reporting during the quarter and no material off-balance-sheet arrangements other than operating leases.

Important facts for investors to verify

  • Whether aerospace and defense demand improved as management expected, and how customer shutdowns or order changes affected sales.
  • Whether margins stabilize despite lower volume, higher overhead, depreciation, health-care costs, and SG&A pressures.
  • Actual costs, timing, operational disruption, and realized savings from both plant consolidations.
  • Execution, spending, and utilization plans for the Texas facility and its planned molded-fiber lines.
  • Working-capital trends, capital spending, cash generation, and continued compliance with credit-facility covenants.